337 related articles for article (PubMed ID: 1249918)
1. Effects of aminonucleoside, daunomycin, and adriamycin on carbon oxidation by glomeruli.
Kaplan BS; Renaud L; Drummond KN
Lab Invest; 1976 Feb; 34(2):174-8. PubMed ID: 1249918
[TBL] [Abstract][Full Text] [Related]
2. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
Grond J; Weening JJ; Elema JD
Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
[TBL] [Abstract][Full Text] [Related]
3. Alterations in proteoglycan metabolism in the nephrotic syndrome induced by the aminonucleoside of puromycin.
Klein DJ; Dehnel PJ; Oegema TR; Brown DM
Lab Invest; 1984 May; 50(5):543-51. PubMed ID: 6232422
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of 35sulfate into the glomerular basement membrane in puromycin aminonucleoside nephrosis.
Garin EH; Boggs KP; Burke FC
Int J Pediatr Nephrol; 1985; 6(2):117-20. PubMed ID: 4030221
[TBL] [Abstract][Full Text] [Related]
5. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
[TBL] [Abstract][Full Text] [Related]
6. Substrate-carbon oxidation by isolated rat glomeruli in aminonucleoside nephrosis.
Kaplan BS; Renaud L; Drummond KN
Kidney Int; 1974 Sep; 6(3):170-6. PubMed ID: 4424890
[No Abstract] [Full Text] [Related]
7. Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside.
Hoyer JR; Mauer SM; Michael AF
J Lab Clin Med; 1975 May; 85(5):756-68. PubMed ID: 1091713
[TBL] [Abstract][Full Text] [Related]
8. Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in adriamycin and puromycin nephrosis.
Whiteside C; Prutis K; Cameron R; Thompson J
Lab Invest; 1989 Dec; 61(6):650-60. PubMed ID: 2601299
[TBL] [Abstract][Full Text] [Related]
9. Combined light and electron-microscope morphometric studies of acute puromycin aminonucleoside nephropathy in rats.
Pinto JA; Brewer DB
J Pathol; 1975 Jul; 116(3):149-64. PubMed ID: 1104792
[TBL] [Abstract][Full Text] [Related]
10. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
[TBL] [Abstract][Full Text] [Related]
11. Glomerular basement membrane heparan sulfate glycosaminoglycan in aminonucleoside of puromycin nephrosis.
Garin EH; Shirey AJ
Child Nephrol Urol; 1988-1989; 9(3):121-6. PubMed ID: 2978121
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
Yamashita J; Nakajima K; Ohno Y; Kaneshiro Y; Matsuo T; Tanaka H; Kaneko K
Eur J Pharmacol; 2008 Jul; 589(1-3):239-44. PubMed ID: 18541230
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis.
Kokui K; Yoshikawa N; Nakamura H; Itoh H
J Pathol; 1992 Mar; 166(3):297-301. PubMed ID: 1517884
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship for two lipoxygenase inhibitors and their potential for inducing nephrotic syndrome.
Morley TJ; Evans GO; Goodwin DA; Read NG; Hodgson ST; Hawksworth GM
Toxicol Appl Pharmacol; 1997 Oct; 146(2):299-308. PubMed ID: 9344898
[TBL] [Abstract][Full Text] [Related]
15. Laminin in glomerular basement membranes of aminonucleoside nephrotic rats. Increased proteinuria induced by antilaminin immunoglobulin G.
Abrahamson DR; Hein A; Caulfield JP
Lab Invest; 1983 Jul; 49(1):38-47. PubMed ID: 6865329
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
Schwartz MM; Sharon Z; Pauli BU; Lewis EJ
Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977
[TBL] [Abstract][Full Text] [Related]
17. Steroids and Adriamycin nephrosis.
Bertani T; Remuzzi G; Rocchi G; Delaini F; Sacchi G; Falchetti M; Donati MB
Appl Pathol; 1984; 2(1):32-8. PubMed ID: 6525317
[TBL] [Abstract][Full Text] [Related]
18. Glomerular expression of smooth-muscle myosin heavy-chain isoforms in aminonucleoside nephrosis in rats.
Nakamura T; Kimura K; Ebihara I; Takahashi T; Tomino Y; Aikawa M; Yazaki Y; Nagai R; Koide H
Clin Sci (Lond); 1995 Jul; 89(1):45-52. PubMed ID: 7671567
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
Pedraza-Chaverrí J; Cruz C; Ibarra-Rubio ME; Chávez MT; Calleja C; Tapia E; del Carmen Uribe M; Romero L; Peña JC
Rev Invest Clin; 1990; 42(1):29-38. PubMed ID: 2236972
[TBL] [Abstract][Full Text] [Related]
20. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
Ricardo SD; Bertram JF; Ryan GB
Exp Nephrol; 1995; 3(5):270-9. PubMed ID: 7583048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]